Approximately 26 percent of the U.S. population has impaired fasting glucose, which is a predisposition for developing type 2 diabetes, and chromium supplementation has been suggested as a method…
diabetic
Proteomics International biomarker study moves closer to a CDx test for diabetic kidney disease
Drug discovery company Proteomics International has completed an important milestone towards the development of a companion diagnostic (CDx) test with the validation of several of its protein…